Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Dec/02/2020 48 4
Apilimod Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020 3 0
Hanfangchin A Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 2 0
Elopiprazole Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
MLN-3897 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
KW-8232 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
DS-6930 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
N-tert-Butylisoquine Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
ONO 5334 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0
AMG-2674 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 1 0